TrimRx's Blog
Metabolic Adaptation: Why Diets Fail and What Actually Works
If you have ever lost 20 pounds and watched it creep back, your body was doing exactly what evolution shaped it to do.
Menopause and GLP-1: Managing Weight During Hormonal Changes
The 40s and 50s bring metabolic changes that frustrate even the most disciplined women.
Melanotan II: The Tanning Peptide (Risks & Realities)
Introduction Melanotan II is a synthetic melanocortin receptor agonist developed in the 1980s at the University of Arizona as part of a research program…
Medvi Reviews vs TrimRx Reviews: What Customers Actually Say
Medvi and TrimRx both operate in the compounded GLP-1 weight loss telehealth category.
Medicare and GLP-1: Will Government Programs Cover Weight Loss Drugs?
Medicare’s relationship with GLP-1 drugs is the single most important coverage question in US healthcare policy.
What to Do When Medicare Denies Zepbound: Step-by-Step Appeal
Medicare denials for Zepbound are frustrating because the rules changed in late 2024 and most prescribers and pharmacists haven’t caught up.
What to Do When Medicare Denies Wegovy: Appeal Strategy
Medicare denying Wegovy is one of the most common and most fixable insurance problems in 2026.
What to Do When Medicaid Denies Zepbound: Step-by-Step Appeal
Medicaid denials for Zepbound (tirzepatide) follow a predictable pattern, and the appeal follows a predictable counter-pattern.
What to Do When Medicaid Denies Wegovy: Appeal Strategy
Medicaid denials for Wegovy are common because anti-obesity medication coverage is optional under federal Medicaid rules.
